ABOUT THE SERVICE
SPOT (Screening Patients with Oculomotor Testing) is a vision diagnostics platform that screens for 75% of binocular disorders in much less time than a full binocular vision exam. SPOT can be administered by any provider that screens for general health problems, including optometrists, physicians, pediatricians, and school nurses. We hope to launch this platform in early 2026.
Information is owner-confirmed
Last updated 2 months ago
Price range
Other products/services from OculoMotor Technologies

VERVE
Biotechnology
N/A
OculoMotor Technologies
United States (US)